2020-November-24 10:43
Society_Culture
2020-October-20  16:22

Iran to Start Coronavirus Vaccine Human Test in Mid-November

TEHRAN (FNA)- Iranian Health Minister Saeed Namaki said that the country has successfully tested its coronavirus vaccine on animals, adding that the human test phase will begin in mid-November.

“The COVID-19 vaccine has been tested successfully on animals and we will start its human test phase in mid-November,” Namaki said on Tuesday, adding, "We have discussed how to make the coronavirus vaccine with the World Health Organization (WHO), and you will hear good news in the near future."

"The phases of coronavirus vaccine testing are being followed by some 5 groups in Iran," he went on to say.

"3 of the 5 groups are taking the necessary measures based on the declared international standards and have made good progress so far," the minister noted.

"If the coronavirus does not change fundamentally, we hope to be able to enter a new phase of treatment in the coming days with the vaccine test," Namaki stated.

In relevant remarks on October 12, he had also said that the country is through with several phases in developing the vaccine and Iranian scientists have tested the vaccine on animals, including monkeys, and earned good results.

Meanwhile, Head of the Headquarters for Executing the Order of Imam Mohammad Mokhber announced on October 13 that coronavirus vaccine produced by Iranian scientists has passed the animal phase and will be tested on humans after receiving a license from the health ministry.

“Two of the 6 tries to produce coronavirus vaccine have arrived in the final phases and several stages of animal tests, including testing and injection of highly strengthened virus, have been conducted on monkeys successfully and the vaccine’s efficiency has been approved and human trials will be carried out soon,” Mokhber said.

He added that after injection of the vaccine to monkeys, the animal’s body monitoring and tests showed no virus, and even the pathological tests showed no signs of the coronavirus.